论文部分内容阅读
本文运用BCC模型以及基于DEA模型的Malmquist生产率指数对我国生物制药行业25家主营生物药品的上市公司2008—2012年的经营绩效进行评估。基于证监会行业标准划分,这25家上市公司有12家属于生物制品业,12家属于生物药品制造业,1家属于其他生物制品业。
This article uses BCC model and Malmquist productivity index based on DEA model to evaluate the operating performance of 25 listed biopharmaceutical companies in China’s biopharmaceutical industry for 2008-2012. Based on the SFC industry standard, 12 of these 25 listed companies are in the biotech industry, 12 are in the biopharmaceutical manufacturing industry and 1 are in other biotech industry.